‘Disappointing news’: Government pulls Clinical Taskforce funding Formed in response to the COVID-19 pandemic, the National Clinical Evidence Taskforce still hopes to attract support for its work.
TGA threatens illegal semaglutide promoters with jail, $1m fines Advertisers and social media influencers have been warned against publicly spruiking the drug for the purposes of weight loss.
Championing and facilitating high standard practice RACGP Quality Care Chair Professor Mark Morgan discusses the importance of clinical guidelines and how the college determines which to publish.
Is the soaring use of ADHD stimulants a cause for concern? Prescriptions for some medications have increased by nearly 4450% in just two years, but experts are divided on whether this signifies long-due relief for patients or a potential for harm.
RACGP backs up-schedule for modified release paracetamol The college is also supporting a proposal for smaller pack sizes but does not favour restricting over-the-counter sales to adults only.
New Australian ADHD guidelines released The guidelines outline recommendations for diagnosis, support and treatment including medications and non-pharmacological options.
GP pushes back against prostate cancer claims Urologists have called for GPs to overhaul prostate cancer screening, stating that not enough men are being tested – but what do the guidelines actually say?
Outcomes from the new CVD risk calculator depend on integration The benefits of updated guidelines will be missed if implementation issues are not urgently addressed, a GP and CVD researcher believe.
All-inclusive sleep health resources to assist GPs New living guidelines for primary care aim to provide GPs with stepwise management options to help patients with common sleep disorders.
In Practice: how patients can be part of advocacy efforts The RACGP has published downloadable resources for practices and patients as part of ongoing advocacy for better investment in general practice.